In vitro characterization of anti-glucosylceramide rabbit antisera

Glycobiology

Volumn 10, Issue 6, 2000, Pages 629-636

  Brade, Lore ^a   Vielhaber, Gabriele ^a   Heinz, Ernst ^b   Brade, Helmut ^c  

^a RESEARCH CENTER BORSTEL   (Germany)

^b BEIERSDORF AG   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Epidermal lipids; Glycolipid antibody; Immunohistochemistry; Thinlayer immunostaining

Indexed keywords

ANTISERUM; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID;

ARTICLE; BIOSYNTHESIS; EPIDERMIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; THIN LAYER CHROMATOGRAPHY;

ORYCTOLAGUS CUNICULUS;

EID: 0034046831     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/10.6.629     Document Type: Article

References (35)

1. Alfonso, M. and Zeuthen, J. (1996) Generation of human monoclonal antibodies against ganglioside antigens and their applications in the diagnosis and therapy of cancer. Acta Oncologica, 35, 287-295.
2. Brady, R.O., Kanfer, J.N. and Shapiro, D. (1965) Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem. Biophys. Res. Commun., 18, 221-225.
3. Cox, P. and Squier, C.A. (1986) Variations in lipids in different layers of porcine epidermis. J. Invest. Dermatol., 87, 741-744.
4. Datta, S.C. and Radin, N.S. (1988) Stimulation of liver growth and DNA synthesis by glucosylceramide. Lipids, 23, 508-510.
5. Döring, T., Holleran, W.M., Potratz, A., Vielhaber, G., Suzuki, K., Elias, P.M. and Sandhoff, K. (1999a) Sphingolipid activator proteins (SAPs) are required for epidermal permeability barrier formation. J. Biol. Chem., 274, 11038-11045.
6. Döring, T., Proia, R.L. and Sandhoff, K. (1999b) Accumulation of protein-bound epidermal glucosylceramides in β-glucocerebrosidase deficient type 2 Gaucher mice. FEBS Lett., 447, 167-170.
7. Elias, P.M. and Friend, D.S. (1975) The permeability barrier in mammalian epidermis. J. Cell Biol., 65, 180-191.
8. Elias, P.M. and Menon, G.K. (1991) Structural an lipid biochemical correlates of the epidermal permeability barrier. Adv. Lipid Res., 33, 301-313.
9. Forslind, B., Engström, S., Engblom, J. and Norlén L. (1997) A novel approach to the understanding of human skin barrier function. J. Dermatol. Sci., 14, 115-125.
10. Fredman, P. and Lekman, A. (1997) Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders. Neurochem. Res., 22, 1071-1083.
11. Freinkel, R.K. and Traczyk, T.N. (1985) Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J. Invest. Dermatol., 85, 295-298.
12. Gornati, R., Bembi, B., Tong, X., Boscolo, R. and Berra, B. (1998) Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy. Clin. Chim. Acta, 271, 151-161.
13. Grayson, S., Johnson-Winegar, A.G., Wintroub, B.U., Isseroff, R.R., Epstein, E.H. and Elias, P.M. (1985) Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J. Invest. Dermatol., 85, 289-294.
14. Hakomori, S.-I. and Zhang, Y. (1997) Glycosphingolipid antigens and cancer therapy, Chem. Biol., 4, 97-104.
15. Hamakana, S., Asagami, C., Suzuki, M., Inagaki, F. and Suzuki, A. (1989) Structure determination of glucosylβ1-N- (ω-O-linoleoyl)-acylsphingosines of human epidermis. J. Biochem., 105, 684-690.
16. Hamakana, S., Takemoto, T., Hamakana, Y., Asagami, C., Suzuki, M., Suzuki, A. and Otsuka, F. (1993) Structure determination of glycosphingolipids of cultured human keratinocytes. Biochim. Biophys. Acta, 1167, 1-8.
17. Holleran, W.M., Ginns, E.I., Menon, G.K., Grundmann, J.U., Fartasch, M., Elias, P.M. and Sidransky, E. (1994) Consequences of β-glucocerebrosidase deficiency in epidermis: Ulrastructure and permeability barrier alterations in Gaucher disease. J. Clin. Invest., 93, 1756-1764.
18. Holleran, W.M., Takagi, Y., Menon, G.K., Legler, G., Feingold, K.R. and Elias, P.M. (1993) Processing of epidermal glucosylceramide is required for optimal mammalian cutaneous permeability function. J. Clin. Invest., 91, 1656-1664.
19. Ichikawa, S. and Hirabayashi, Y. (1998) Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol., 8, 198-202.
20. Lampe, M.A., Williams, M.L., Elias, P.M. (1983) Human epidermal lipids: characterization and modulations during differentiation. J. Lipid Res., 24, 131-140.
21. Lavie, Y., Cao, H.-T., Bursten, S.L., Giuliano, A.E. and Cabot, M.C. (1996) Accumulation of glucosylceramide in multidrug resistant cancer cells. J. Biol. Chem., 271, 19530-19536.
22. Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A.E. and Cabot, M.C. (1997) Agents that reverse multidrug resistance, tamixofen, verapamil and cyclosporin A, block glycosphingolipid metabolism by inhibiting glycosylation in human cancer cells. J. Biol. Chem., 272, 1682-1687.
23. Marsh, N.L., Elias, P.M. and Holleran, W.M. (1995) Glucosylceramides stimulate epidermal hyperproliferation. J. Clin. Invest., 95, 2903-2909.
24. Nemes, Z. and Steinert, P.M. (1999) Bricks and mortar of the epidermal barrier. Exp. Mol. Med., 31, 5-19.
25. Pfeiffer, S., Vielhaber, G., Vietzke, J.-P., Wittern, K.-P., Hintze, U. and Wepf, R. High-pressure freezing provides new information on human epidermis: simultaneous protein antigen and lamellar lipid structure preservation. J. Invest. Dermatol., forthcoming.
26. Sando, G.N., Howard, E.J. and Madison, K.C. (1996) Induction of ceramide glucosyltransferase activity in cultured keratinocytes: correlation with culture differentiation. J. Biol. Chem., 271, 22044-22051.
27. Schwarz, A. and Futerman, A.H. (1997) Distinct roles for ceramide and glucosyceramide at different stages of neuronal growth. J. Neurosci., 17, 2929-2938.
28. Shayman, J.A., Deshmukh, G.D., Mahdiyoun, S., Thomas, T.P., Wu, D., Barcelon, F.S. and Radin, N.S. (1991) Modulation of renal epithelial growth by glucosylceramide. Association with protein kinase C, sphingosine and diacylglycerol. J. Biol. Chem., 266, 22968-22974.
29. Sidransky, E., Fartasch, M., Lee, R.E., Metlay, L.A., Abella, S., Zimran, A., Gao, W., Elias, P.M., Ginns, E.I. and Holleran, W.M. (1996) Epidermal abnormalities may distinguish type 2 form type 1 and type 3 of Gaucher diease. Pediatr. Res., 39, 134-141.
30. Swartzendruber, D.C., Wertz, P.W., Madison, K.C. and Downing, D.T. (1987) Evidenee that the corneocyte has a chemically bound lipid envelope. J. Invest. Dermatol., 88, 709-713.
31. Uchida, Y., Iwamori, M. and Nagai, Y. (1990) Activation of keratinization of keratinocytes from fetal rat skin with N- (O-linoleoyl) omega-hydroxy fatty acid acyl sphingosyl glucose (lipokeratogenoside) as a marker of epidermis. Biochem. Biophys. Res. Commun., 170, 162-168.
32. Wertz, P.W. and Downing, D.T. (1983) Glucosylceramides of pig epidermis. J. Lipid. Res., 24, 1135-1139.
33. Wertz, P.W., Madison, K.C. and Downing, D.T. (1989) Covalently bound lipids of human stratum corneum. J. Invest. Dermatol., 92, 109-111.
34. Yao, J.K. and Yoshino, J.E. (1994) Association of glucocerebroside homolog biosynthesis with Schwann cell proliferation. Neurochem. Res., 19, 31-35.
35. Yardley, H. (1983) Epidermal Lipids: Biochemistry and Physiology of the Skin, Goldsmith, L. (ed.). Oxford University Press, New York, pp. 363-381.